Urological Cancer Drugs Market Research: Global Status & Forecast by Geography, Type & Application (2017-2027)
  • ID: 50798
  • July 12, 2021
  • 83 pages
  • 99 Strategy

According to 99Strategy, the Global Urological Cancer Drugs Market is estimated to reach xxx million USD in 2021 and projected to grow at the CAGR of xx% during the 2022-2027. The report analyses the global Urological Cancer Drugs market, the market size and growth, as well as the major market participants.
The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels.The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.
Key Regions
Asia Pacific
North America
Europe
South America
Middle East & Africa
Key Companies
Novartis
Pfizer
Johnson & Johnson
AstraZeneca
Astellas
Bristol-Myers Squibb
Abbott Laboratories
Celgene Corporation
Dendreon Corporation
Ferring Pharmaceuticals
GlaxoSmithKline
Indevus Pharmaceuticals Inc
Ipsen
Roche Healthcare
Sanofi S.A.
Tolmar Inc
Key Product Type
Xofigo (Radium Ra 223 Dichloride)
Jevtana (Cabazitaxel)
Inlyta (Axitinib)
Votrient (Pazopanib Hydrochloride)
Sutent (Sunitinib Malate)
Zytiga (Abiraterone Acetate)
Xtandi (Enzalutamide)
Opdivo (Nivolumab)
Provenge (Sipuleucel-T)
Market by Application
Prostate Cancer
Bladder Cancer
Kidney Cancer
Testicular Cancer
Main Aspects covered in the Report
Overview of the Urological Cancer Drugs market including production, consumption, status & forecast and market growth
2017-2021 historical data and 2022-2027 market forecast
Geographical analysis including major countries
Overview the product type market including development
Overview the end-user market including development

Table of Content
1 Industrial Chain Overview
1.1 Urological Cancer Drugs Industry
1.1.1 Overview
Figure Urological Cancer Drugs Picture List
1.1.2 Characteristics of Urological Cancer Drugs
1.2 Upstream
1.2.1 Major Materials
1.2.2 Manufacturing Overview
1.3 Product List By Type
1.3.1 Xofigo (Radium Ra 223 Dichloride)
1.3.2 Jevtana (Cabazitaxel)
1.3.3 Inlyta (Axitinib)
1.3.4 Votrient (Pazopanib Hydrochloride)
1.3.5 Sutent (Sunitinib Malate)
1.3.6 Zytiga (Abiraterone Acetate)
1.3.7 Xtandi (Enzalutamide)
1.3.8 Opdivo (Nivolumab)
1.3.9 Provenge (Sipuleucel-T)
1.4 End-Use List
1.4.1 Demand in Prostate Cancer
1.4.2 Demand in Bladder Cancer
1.4.3 Demand in Kidney Cancer
1.4.4 Demand in Testicular Cancer
1.5 Global Market Overview
1.5.1 Global Market Size and Forecast, 2017-2027
Figure Global Market Size and Forecast with Growth Rate, 2017-2027
1.5.2 Global Market Size and Forecast by Geography with CAGR, 2017-2027
Table Global Market Size and Forecast by Geography with Growth Rate, 2017-2027
1.5.3 Global Market Size and Forecast by Product Type with CAGR, 2017-2027
Table Global Market Size and Forecast by Type with Growth Rate, 2017-2027
1.5.4 Global Market Size and Forecast by End-Use with CAGR, 2017-2027
Table Global Market Size and Forecast by End-Use with Growth Rate, 2017-2027
2 Global Production & Consumption by Geography
2.1 Global Production & Consumption
2.1.1 Global Production
Figure Global Production Volume Status and Growth Rate, 2017-2021, in Volume
Table Global Production Volume Status and Growth Rate by Geography, 2017-2021, in Volume
Figure Global Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table Global Production Amount Status and Growth Rate by Geography, 2017-2021, in Million USD
2.1.2 Global Consumption
Figure Global Market Volume and Growth Rate, 2017-2021, in Volume
Table Global Market Volume and Growth Rate by Geography, 2017-2021, in Volume
Figure Global Market Amount and Growth Rate, 2017-2021, in Million USD
Table Global Market Amount and Growth Rate by Geography, 2017-2021, in Million USD
2.2 Geographic Production & Consumption
2.2.1 Production
2.2.1.1 Asia-Pacific
Figure Asia-Pacific Production Volume Status and Growth Rate, 2017-2021, in Volume
Table Asia-Pacific Production Volume Status and Growth Rate by Region, 2017-2021, in Volume
Figure Asia-Pacific Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
2.2.1.2 North America
Figure North America Production Volume Status and Growth Rate, 2017-2021, in Volume
Table North America Production Volume Status and Growth Rate by Region, 2017-2021, in Volume
Figure North America Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table North America Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
2.2.1.3 South America
Figure South America Production Volume Status and Growth Rate, 2017-2021, in Volume
Table South America Production Volume Status and Growth Rate by Region, 2017-2021, in Volume
Figure South America Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table South America Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
2.2.1.4 Europe
Figure Europe Production Volume Status and Growth Rate, 2017-2021, in Volume
Table Europe Production Volume Status and Growth Rate by Region, 2017-2021, in Volume
Figure Europe Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table Europe Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
2.2.1.5 Middle East & Africa
Figure Middle East & Africa Production Volume Status and Growth Rate, 2017-2021, in Volume
Table Middle East & Africa Production Volume Status and Growth Rate by Region, 2017-2021, in Volume
Figure Middle East & Africa Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
2.2.2 Consumption
2.2.2.1 Asia-Pacific
Figure Asia-Pacific Market Volume and Growth Rate, 2017-2021, in Volume
Table Asia-Pacific Market Volume and Growth Rate by Region, 2017-2021, in Volume
Figure Asia-Pacific Market Amount and Growth Rate, 2017-2021, in Million USD
Table Asia-Pacific Market Amount and Growth Rate by Region, 2017-2021, in Million USD
2.2.2.2 North America
Figure North America Market Volume and Growth Rate, 2017-2021, in Volume
Table North America Market Volume and Growth Rate by Region, 2017-2021, in Volume
Figure North America Market Amount and Growth Rate, 2017-2021, in Million USD
Table North America Market Amount and Growth Rate by Region, 2017-2021, in Million USD
2.2.2.3 South America
Figure South America Market Volume and Growth Rate, 2017-2021, in Volume
Table South America Market Volume and Growth Rate by Region, 2017-2021, in Volume
Figure South America Market Amount and Growth Rate, 2017-2021, in Million USD
Table South America Market Amount and Growth Rate by Region, 2017-2021, in Million USD
2.2.2.4 Europe
Figure Europe Market Volume and Growth Rate, 2017-2021, in Volume
Table Europe Market Volume and Growth Rate by Region, 2017-2021, in Volume
Figure Europe Market Amount and Growth Rate, 2017-2021, in Million USD
Table Europe Market Amount and Growth Rate by Region, 2017-2021, in Million USD
2.2.2.5 Middle East & Africa
Figure Middle East & Africa Market Volume and Growth Rate, 2017-2021, in Volume
Table Middle East & Africa Market Volume and Growth Rate by Region, 2017-2021, in Volume
Figure Middle East & Africa Market Amount and Growth Rate, 2017-2021, in Million USD
Table Middle East & Africa Market Amount and Growth Rate by Region, 2017-2021, in Million USD
3 Major Manufacturers Introduction
3.1 Manufacturers Overview
Table Major Manufacturers Headquarters and Contact Information
Table Major Manufacturers Capacity List in 2021
3.2 Manufacturers List
3.2.1 Novartis Overview
Table Novartis Overview List
3.2.1.1 Product Specifications
3.2.1.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Urological Cancer Drugs Business Operation of Novartis (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.1.3 Recent Developments
3.2.1.4 Future Strategic Planning
3.2.2 Pfizer Overview
Table Pfizer Overview List
3.2.2.1 Product Specifications
3.2.2.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Urological Cancer Drugs Business Operation of Pfizer (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.2.3 Recent Developments
3.2.2.4 Future Strategic Planning
3.2.3 Johnson & Johnson Overview
Table Johnson & Johnson Overview List
3.2.3.1 Product Specifications
3.2.3.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Urological Cancer Drugs Business Operation of Johnson & Johnson (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.3.3 Recent Developments
3.2.3.4 Future Strategic Planning
3.2.4 AstraZeneca Overview
Table AstraZeneca Overview List
3.2.4.1 Product Specifications
3.2.4.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Urological Cancer Drugs Business Operation of AstraZeneca (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.4.3 Recent Developments
3.2.4.4 Future Strategic Planning
3.2.5 Astellas Overview
Table Astellas Overview List
3.2.5.1 Product Specifications
3.2.5.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Urological Cancer Drugs Business Operation of Astellas (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.5.3 Recent Developments
3.2.5.4 Future Strategic Planning
3.2.6 Bristol-Myers Squibb Overview
Table Bristol-Myers Squibb Overview List
3.2.6.1 Product Specifications
3.2.6.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Urological Cancer Drugs Business Operation of Bristol-Myers Squibb (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.6.3 Recent Developments
3.2.6.4 Future Strategic Planning
3.2.7 Abbott Laboratories Overview
Table Abbott Laboratories Overview List
3.2.7.1 Product Specifications
3.2.7.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Urological Cancer Drugs Business Operation of Abbott Laboratories (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.7.3 Recent Developments
3.2.7.4 Future Strategic Planning
3.2.8 Celgene Corporation Overview
Table Celgene Corporation Overview List
3.2.8.1 Product Specifications
3.2.8.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Urological Cancer Drugs Business Operation of Celgene Corporation (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.8.3 Recent Developments
3.2.8.4 Future Strategic Planning
3.2.9 Dendreon Corporation Overview
Table Dendreon Corporation Overview List
3.2.9.1 Product Specifications
3.2.9.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Urological Cancer Drugs Business Operation of Dendreon Corporation (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.9.3 Recent Developments
3.2.9.4 Future Strategic Planning
3.2.10 Ferring Pharmaceuticals Overview
Table Ferring Pharmaceuticals Overview List
3.2.10.1 Product Specifications
3.2.10.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Urological Cancer Drugs Business Operation of Ferring Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.10.3 Recent Developments
3.2.10.4 Future Strategic Planning
3.2.11 GlaxoSmithKline Overview
Table GlaxoSmithKline Overview List
3.2.11.1 Product Specifications
3.2.11.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Urological Cancer Drugs Business Operation of GlaxoSmithKline (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.11.3 Recent Developments
3.2.11.4 Future Strategic Planning
3.2.12 Indevus Pharmaceuticals Inc Overview
Table Indevus Pharmaceuticals Inc Overview List
3.2.12.1 Product Specifications
3.2.12.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Urological Cancer Drugs Business Operation of Indevus Pharmaceuticals Inc (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.12.3 Recent Developments
3.2.12.4 Future Strategic Planning
3.2.13 Ipsen Overview
Table Ipsen Overview List
3.2.13.1 Product Specifications
3.2.13.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Urological Cancer Drugs Business Operation of Ipsen (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.13.3 Recent Developments
3.2.13.4 Future Strategic Planning
3.2.14 Roche Healthcare Overview
Table Roche Healthcare Overview List
3.2.14.1 Product Specifications
3.2.14.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Urological Cancer Drugs Business Operation of Roche Healthcare (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.14.3 Recent Developments
3.2.14.4 Future Strategic Planning
3.2.15 Sanofi S.A. Overview
Table Sanofi S.A. Overview List
3.2.15.1 Product Specifications
3.2.15.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Urological Cancer Drugs Business Operation of Sanofi S.A. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.15.3 Recent Developments
3.2.15.4 Future Strategic Planning
3.2.16 Tolmar Inc Overview
Table Tolmar Inc Overview List
3.2.16.1 Product Specifications
3.2.16.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Urological Cancer Drugs Business Operation of Tolmar Inc (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.16.3 Recent Developments
3.2.16.4 Future Strategic Planning
4 Market Competition Pattern
4.1 Market Size and Sketch
Figure Global Market Size and Growth Rate, 2017-2021, in Volume
Figure Global Market Size and Growth Rate, 2017-2021, in Million USD
Figure Global Competition Sketch Overview
4.2 Company Market Share
4.2.1 Global Production by Major Manufacturers
Table Global Production Volume List by Manufacturers, 2017-2021, in Volume
Table Global Production Volume Share List by Manufacturers, 2017-2021, in Volume
Figure Global Production Volume Share by Manufacturers in 2021, in Volume
Table Global Production Amount List by Manufacturers, 2017-2021, in Million USD
Table Global Production Amount Share List by Manufacturers, 2017-2021, in Million USD
Figure Global Production Amount Share by Manufacturers in 2021, in Million USD
4.2.2 Market Concentration Analysis
4.3 Market News and Trend
4.3.1 Merger & Acquisition
4.3.2 New Product Launch
5 Product Type Segment
5.1 Global Overview by Product Type Segment
Table Global Market Status and Growth Rate by Product Type Segment, 2017-2021, in Million USD
Table Global Market Status and Growth Rate by Product Type Segment 2017-2021, in Volume
5.2 Segment Subdivision by Product Type
5.2.1 Market in Xofigo (Radium Ra 223 Dichloride)
5.2.1.1 Market Size
Figure Global Market Amount and Growth Rate in Xofigo (Radium Ra 223 Dichloride), 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Xofigo (Radium Ra 223 Dichloride), 2017-2021, in Volume
5.2.1.2 Situation & Development
5.2.2 Market in Jevtana (Cabazitaxel)
5.2.2.1 Market Size
Figure Global Market Amount and Growth Rate in Jevtana (Cabazitaxel), 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Jevtana (Cabazitaxel), 2017-2021, in Volume
5.2.2.2 Situation & Development
5.2.3 Market in Inlyta (Axitinib)
5.2.3.1 Market Size
Figure Global Market Amount and Growth Rate in Inlyta (Axitinib), 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Inlyta (Axitinib), 2017-2021, in Volume
5.2.3.2 Situation & Development
5.2.4 Market in Votrient (Pazopanib Hydrochloride)
5.2.4.1 Market Size
Figure Global Market Amount and Growth Rate in Votrient (Pazopanib Hydrochloride), 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Votrient (Pazopanib Hydrochloride), 2017-2021, in Volume
5.2.4.2 Situation & Development
5.2.5 Market in Sutent (Sunitinib Malate)
5.2.5.1 Market Size
Figure Global Market Amount and Growth Rate in Sutent (Sunitinib Malate), 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Sutent (Sunitinib Malate), 2017-2021, in Volume
5.2.5.2 Situation & Development
5.2.6 Market in Zytiga (Abiraterone Acetate)
5.2.6.1 Market Size
Figure Global Market Amount and Growth Rate in Zytiga (Abiraterone Acetate), 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Zytiga (Abiraterone Acetate), 2017-2021, in Volume
5.2.6.2 Situation & Development
5.2.7 Market in Xtandi (Enzalutamide)
5.2.7.1 Market Size
Figure Global Market Amount and Growth Rate in Xtandi (Enzalutamide), 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Xtandi (Enzalutamide), 2017-2021, in Volume
5.2.7.2 Situation & Development
5.2.8 Market in Opdivo (Nivolumab)
5.2.8.1 Market Size
Figure Global Market Amount and Growth Rate in Opdivo (Nivolumab), 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Opdivo (Nivolumab), 2017-2021, in Volume
5.2.8.2 Situation & Development
5.2.9 Market in Provenge (Sipuleucel-T)
5.2.9.1 Market Size
Figure Global Market Amount and Growth Rate in Provenge (Sipuleucel-T), 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Provenge (Sipuleucel-T), 2017-2021, in Volume
5.2.9.2 Situation & Development
6 End-Use Segment
6.1 Global Overview by End-Use Segment
Table Global Market Status and Growth Rate by End-Use Segment, 2017-2021, in Million USD
Table Global Market Status and Growth Rate by End-Use Segment 2017-2021, in Volume
6.2 Segment Subdivision
6.2.1 Market in Prostate Cancer
6.2.1.1 Market Size
Figure Global Market Amount and Growth Rate in Prostate Cancer, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Prostate Cancer, 2017-2021, in Volume
6.2.1.2 Situation & Development
6.2.2 Market in Bladder Cancer
6.2.2.1 Market Size
Figure Global Market Amount and Growth Rate in Bladder Cancer, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Bladder Cancer, 2017-2021, in Volume
6.2.2.2 Situation & Development
6.2.3 Market in Kidney Cancer
6.2.3.1 Market Size
Figure Global Market Amount and Growth Rate in Kidney Cancer, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Kidney Cancer, 2017-2021, in Volume
6.2.3.2 Situation & Development
6.2.4 Market in Testicular Cancer
6.2.4.1 Market Size
Figure Global Market Amount and Growth Rate in Testicular Cancer, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Testicular Cancer, 2017-2021, in Volume
6.2.4.2 Situation & Development
7 Market Forecast & Trend
7.1 Regional Forecast
Table Global Market Forecast by Region Segment 2022-2027, in Million USD
Table Global Market Forecast by Region Segment 2022-2027, in Volume
7.2 Consumption Forecast
7.2.1 Product Type Forecast
Table Global Market Amount by Product Type Segment 2022-2027, in Million USD
Table Global Market Volume by Product Type Segment 2022-2027, in Volume
7.2.2 End-Use Forecast
Table Global Market Amount by End-Use Segment 2022-2027, in Million USD
Table Global Market Volume by End-Use Segment 2022-2027, in Volume
7.3 Investment Trend
7.4 Consumption Trend
8 Price & Channel
8.1 Price and Cost
8.1.1 Price
8.1.2 Cost
Figure Cost Component Ratio
8.2 Channel Segment
9 Market Drivers & Investment Environment
9.1 Market Drivers
9.2 Investment Environment
9.3 Impact of Coronavirus on the Urological Cancer Drugs Industry
9.3.1 Impact on Industry Upstream
9.3.2 Impact on Industry Downstream
9.3.3 Impact on Industry Channels
9.3.4 Impact on Industry Competition
9.3.5 Impact on Industry Employment
10 Research Conclusion

List of Table
Table Global Market Size and Forecast by Geography with Growth Rate, 2017-2027
Table Global Market Size and Forecast by Type with Growth Rate, 2017-2027
Table Global Market Size and Forecast by End-Use with Growth Rate, 2017-2027
Table Global Production Volume Status and Growth Rate by Geography, 2017-2021, in Volume
Table Global Production Amount Status and Growth Rate by Geography, 2017-2021, in Million USD
Table Global Market Volume and Growth Rate by Geography, 2017-2021, in Volume
Table Global Market Amount and Growth Rate by Geography, 2017-2021, in Million USD
Table Asia-Pacific Production Volume Status and Growth Rate by Region, 2017-2021, in Volume
Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
Table North America Production Volume Status and Growth Rate by Region, 2017-2021, in Volume
Table North America Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
Table South America Production Volume Status and Growth Rate by Region, 2017-2021, in Volume
Table South America Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
Table Europe Production Volume Status and Growth Rate by Region, 2017-2021, in Volume
Table Europe Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
Table Middle East & Africa Production Volume Status and Growth Rate by Region, 2017-2021, in Volume
Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
Table Asia-Pacific Market Volume and Growth Rate by Region, 2017-2021, in Volume
Table Asia-Pacific Market Amount and Growth Rate by Region, 2017-2021, in Million USD
Table North America Market Volume and Growth Rate by Region, 2017-2021, in Volume
Table North America Market Amount and Growth Rate by Region, 2017-2021, in Million USD
Table South America Market Volume and Growth Rate by Region, 2017-2021, in Volume
Table South America Market Amount and Growth Rate by Region, 2017-2021, in Million USD
Table Europe Market Volume and Growth Rate by Region, 2017-2021, in Volume
Table Europe Market Amount and Growth Rate by Region, 2017-2021, in Million USD
Table Middle East & Africa Market Volume and Growth Rate by Region, 2017-2021, in Volume
Table Middle East & Africa Market Amount and Growth Rate by Region, 2017-2021, in Million USD
Table Major Manufacturers Headquarters and Contact Information
Table Major Manufacturers Capacity List in 2021
Table Novartis Overview List
Table Urological Cancer Drugs Business Operation of Novartis (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Pfizer Overview List
Table Urological Cancer Drugs Business Operation of Pfizer (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Johnson & Johnson Overview List
Table Urological Cancer Drugs Business Operation of Johnson & Johnson (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table AstraZeneca Overview List
Table Urological Cancer Drugs Business Operation of AstraZeneca (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Astellas Overview List
Table Urological Cancer Drugs Business Operation of Astellas (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Bristol-Myers Squibb Overview List
Table Urological Cancer Drugs Business Operation of Bristol-Myers Squibb (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Abbott Laboratories Overview List
Table Urological Cancer Drugs Business Operation of Abbott Laboratories (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Celgene Corporation Overview List
Table Urological Cancer Drugs Business Operation of Celgene Corporation (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Dendreon Corporation Overview List
Table Urological Cancer Drugs Business Operation of Dendreon Corporation (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Ferring Pharmaceuticals Overview List
Table Urological Cancer Drugs Business Operation of Ferring Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table GlaxoSmithKline Overview List
Table Urological Cancer Drugs Business Operation of GlaxoSmithKline (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Indevus Pharmaceuticals Inc Overview List
Table Urological Cancer Drugs Business Operation of Indevus Pharmaceuticals Inc (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Ipsen Overview List
Table Urological Cancer Drugs Business Operation of Ipsen (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Roche Healthcare Overview List
Table Urological Cancer Drugs Business Operation of Roche Healthcare (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Sanofi S.A. Overview List
Table Urological Cancer Drugs Business Operation of Sanofi S.A. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Tolmar Inc Overview List
Table Urological Cancer Drugs Business Operation of Tolmar Inc (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Global Production Volume List by Manufacturers, 2017-2021, in Volume
Table Global Production Volume Share List by Manufacturers, 2017-2021, in Volume
Table Global Production Amount List by Manufacturers, 2017-2021, in Million USD
Table Global Production Amount Share List by Manufacturers, 2017-2021, in Million USD
Table Global Market Status and Growth Rate by Product Type Segment, 2017-2021, in Million USD
Table Global Market Status and Growth Rate by Product Type Segment 2017-2021, in Volume
Table Global Market Status and Growth Rate by End-Use Segment, 2017-2021, in Million USD
Table Global Market Status and Growth Rate by End-Use Segment 2017-2021, in Volume
Table Global Market Forecast by Region Segment 2022-2027, in Million USD
Table Global Market Forecast by Region Segment 2022-2027, in Volume
Table Global Market Amount by Product Type Segment 2022-2027, in Million USD
Table Global Market Volume by Product Type Segment 2022-2027, in Volume
Table Global Market Amount by End-Use Segment 2022-2027, in Million USD
Table Global Market Volume by End-Use Segment 2022-2027, in Volume

List of Figure
Figure Urological Cancer Drugs Picture List
Figure Global Market Size and Forecast with Growth Rate, 2017-2027
Figure Global Production Volume Status and Growth Rate, 2017-2021, in Volume
Figure Global Production Amount Status and Growth Rate, 2017-2021, in Million USD
Figure Global Market Volume and Growth Rate, 2017-2021, in Volume
Figure Global Market Amount and Growth Rate, 2017-2021, in Million USD
Figure Asia-Pacific Production Volume Status and Growth Rate, 2017-2021, in Volume
Figure Asia-Pacific Production Amount Status and Growth Rate, 2017-2021, in Million USD
Figure North America Production Volume Status and Growth Rate, 2017-2021, in Volume
Figure North America Production Amount Status and Growth Rate, 2017-2021, in Million USD
Figure South America Production Volume Status and Growth Rate, 2017-2021, in Volume
Figure South America Production Amount Status and Growth Rate, 2017-2021, in Million USD
Figure Europe Production Volume Status and Growth Rate, 2017-2021, in Volume
Figure Europe Production Amount Status and Growth Rate, 2017-2021, in Million USD
Figure Middle East & Africa Production Volume Status and Growth Rate, 2017-2021, in Volume
Figure Middle East & Africa Production Amount Status and Growth Rate, 2017-2021, in Million USD
Figure Asia-Pacific Market Volume and Growth Rate, 2017-2021, in Volume
Figure Asia-Pacific Market Amount and Growth Rate, 2017-2021, in Million USD
Figure North America Market Volume and Growth Rate, 2017-2021, in Volume
Figure North America Market Amount and Growth Rate, 2017-2021, in Million USD
Figure South America Market Volume and Growth Rate, 2017-2021, in Volume
Figure South America Market Amount and Growth Rate, 2017-2021, in Million USD
Figure Europe Market Volume and Growth Rate, 2017-2021, in Volume
Figure Europe Market Amount and Growth Rate, 2017-2021, in Million USD
Figure Middle East & Africa Market Volume and Growth Rate, 2017-2021, in Volume
Figure Middle East & Africa Market Amount and Growth Rate, 2017-2021, in Million USD
Figure Global Market Size and Growth Rate, 2017-2021, in Volume
Figure Global Market Size and Growth Rate, 2017-2021, in Million USD
Figure Global Competition Sketch Overview
Figure Global Production Volume Share by Manufacturers in 2021, in Volume
Figure Global Production Amount Share by Manufacturers in 2021, in Million USD
Figure Global Market Amount and Growth Rate in Xofigo (Radium Ra 223 Dichloride), 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Xofigo (Radium Ra 223 Dichloride), 2017-2021, in Volume
Figure Global Market Amount and Growth Rate in Jevtana (Cabazitaxel), 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Jevtana (Cabazitaxel), 2017-2021, in Volume
Figure Global Market Amount and Growth Rate in Inlyta (Axitinib), 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Inlyta (Axitinib), 2017-2021, in Volume
Figure Global Market Amount and Growth Rate in Votrient (Pazopanib Hydrochloride), 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Votrient (Pazopanib Hydrochloride), 2017-2021, in Volume
Figure Global Market Amount and Growth Rate in Sutent (Sunitinib Malate), 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Sutent (Sunitinib Malate), 2017-2021, in Volume
Figure Global Market Amount and Growth Rate in Zytiga (Abiraterone Acetate), 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Zytiga (Abiraterone Acetate), 2017-2021, in Volume
Figure Global Market Amount and Growth Rate in Xtandi (Enzalutamide), 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Xtandi (Enzalutamide), 2017-2021, in Volume
Figure Global Market Amount and Growth Rate in Opdivo (Nivolumab), 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Opdivo (Nivolumab), 2017-2021, in Volume
Figure Global Market Amount and Growth Rate in Provenge (Sipuleucel-T), 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Provenge (Sipuleucel-T), 2017-2021, in Volume
Figure Global Market Amount and Growth Rate in Prostate Cancer, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Prostate Cancer, 2017-2021, in Volume
Figure Global Market Amount and Growth Rate in Bladder Cancer, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Bladder Cancer, 2017-2021, in Volume
Figure Global Market Amount and Growth Rate in Kidney Cancer, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Kidney Cancer, 2017-2021, in Volume
Figure Global Market Amount and Growth Rate in Testicular Cancer, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Testicular Cancer, 2017-2021, in Volume
Figure Cost Component Ratio

None

None

Custom Research

Looking for more specific research study and analysis? Contact our Custom Research Team

Write to Custom Research Team